Utilizing Index of Refraction Monitors in Biopharmaceutical Downstream Processing and Purification When the FDA published the 2003 document, “Pharmaceutical Current Good Manufacturing Practices (CGMPs ...
High production volumes and the need for continuous optimization during manufacturing processes mean that traditional lab-based quality control methods can no longer deliver the results required in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback